Viewing Study NCT01590628


Ignite Creation Date: 2025-12-26 @ 11:10 AM
Ignite Modification Date: 2026-05-02 @ 12:06 AM
Study NCT ID: NCT01590628
Status: COMPLETED
Last Update Posted: 2022-05-20
First Post: 2012-04-15
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Allogeneic SCT of NiCord®, UCB-Derived Ex Vivo Expanded Stem and Progenitor Cells, in Patients With Hemoglobinopathies
Sponsor: Gamida Cell ltd
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Sickle Cell Disease & Thalassemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Sickle Cell Disease & Thalassemia View
None Genetic disorder View